Viewing Study NCT04692051


Ignite Creation Date: 2025-12-24 @ 11:39 PM
Ignite Modification Date: 2026-05-18 @ 2:44 AM
Study NCT ID: NCT04692051
Status: UNKNOWN
Last Update Posted: 2020-12-31
First Post: 2020-12-29
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase II Study for Nab-paclitaxel Plus Cisplatin vs Gemcitabine Plus Cispatin as First Line Chemotherapy in Advanced Biliary Tract Cancer
Sponsor: Huazhong University of Science and Technology
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Biliary Tract Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Nab-paclitaxel + Cisplatin View